Liu S, Shang M, Gong J, Sun H, Hu B
J Cancer. 2025; 16(1):315-330.
PMID: 39744575
PMC: 11660133.
DOI: 10.7150/jca.102618.
Zhu C, Yang Q, Mu X, Zhai Y, Zhao W, Yin Z
Cancer Inform. 2024; 23:11769351241300030.
PMID: 39553336
PMC: 11569503.
DOI: 10.1177/11769351241300030.
Li M, Yang J, Gao L
Heliyon. 2024; 10(20):e39481.
PMID: 39497959
PMC: 11533598.
DOI: 10.1016/j.heliyon.2024.e39481.
Mu S, Zhao K, Zhong S, Wang Y
Biomolecules. 2024; 14(8).
PMID: 39199429
PMC: 11353047.
DOI: 10.3390/biom14081042.
Chen Y, Zhu Z, Zhang L, Wang J, Ren H
Smart Med. 2024; 2(3):e20230008.
PMID: 39188344
PMC: 11235706.
DOI: 10.1002/SMMD.20230008.
Mechanisms and clinical landscape of N6-methyladenosine (m6A) RNA modification in gastrointestinal tract cancers.
Zhu D, Su K, Ou-Yang X, Zhang Y, Yu X, Li Z
Mol Cell Biochem. 2024; 479(7):1553-1570.
PMID: 38856795
PMC: 11254988.
DOI: 10.1007/s11010-024-05040-x.
YTHDF1 regulates immune cell infiltration in gastric cancer via interaction with p53.
Liao Q, Xiong J
Exp Ther Med. 2024; 27(6):255.
PMID: 38682111
PMC: 11046265.
DOI: 10.3892/etm.2024.12543.
VIRMA promotes the progression of head and neck squamous cell carcinoma by regulating mRNA and m6A levels.
Zhu C, Cheng Y, Yu Y, Zhang Y, Ren G
Biomol Biomed. 2024; 24(5):1244-1257.
PMID: 38577917
PMC: 11379021.
DOI: 10.17305/bb.2024.10358.
Landscape of mA RNA methylation regulators in liver cancer and its therapeutic implications.
Zhao J, Li G, Lu X, Zhu L, Gao Q
Front Pharmacol. 2024; 15:1376005.
PMID: 38545555
PMC: 10965734.
DOI: 10.3389/fphar.2024.1376005.
Knowledge mapping and current trends of m6A methylation in the field of cancer.
Zhu C, Yang J, Zhang C, Wang Y, Wang J
Heliyon. 2024; 10(4):e26262.
PMID: 38434062
PMC: 10906179.
DOI: 10.1016/j.heliyon.2024.e26262.
BMP9-ID1 Pathway Attenuates N-Methyladenosine Levels of CyclinD1 to Promote Cell Proliferation in Hepatocellular Carcinoma.
Chen H, Zhang M, Li J, Liu M, Cao D, Li Y
Int J Mol Sci. 2024; 25(2).
PMID: 38256056
PMC: 10816017.
DOI: 10.3390/ijms25020981.
YTHDF1 in Tumor Cell Metabolism: An Updated Review.
Rong H, Wang D, Wang Y, Dong C, Wang G
Molecules. 2024; 29(1).
PMID: 38202722
PMC: 10779796.
DOI: 10.3390/molecules29010140.
Recent Advances in RNA mA Modification in Solid Tumors and Tumor Immunity.
Verghese M, Wilkinson E, He Y
Cancer Treat Res. 2023; 190:95-142.
PMID: 38113000
DOI: 10.1007/978-3-031-45654-1_4.
Construction of an acute myeloid leukemia prognostic model based on m6A-related efferocytosis-related genes.
Wang Y, Bin T, Tang J, Xu X, Lin C, Lu B
Front Immunol. 2023; 14:1268090.
PMID: 38077322
PMC: 10704160.
DOI: 10.3389/fimmu.2023.1268090.
Establishment of a new molecular subtyping and prognostic signature with m6A/m5C/m1A/m7G regulatory genes for hepatocellular carcinoma.
Liu T, Wang Y, Li Z, Sun L, Yang K, Chen J
Heliyon. 2023; 9(11):e21285.
PMID: 38027812
PMC: 10660009.
DOI: 10.1016/j.heliyon.2023.e21285.
Decoding mA mRNA methylation by reader proteins in liver diseases.
Sun L, Chen X, Zhu S, Wang J, Diao S, Liu J
Genes Dis. 2023; 11(2):711-726.
PMID: 37692496
PMC: 10491919.
DOI: 10.1016/j.gendis.2023.02.054.
Ethanolamine-phosphate phospho-lyase (ETNPPL) contributes to the diagnosis, prognosis, and therapy of hepatocellular carcinoma.
Zhang Y, Shen L, Wang B, Wu X
PeerJ. 2023; 11:e15834.
PMID: 37637156
PMC: 10448887.
DOI: 10.7717/peerj.15834.
Building an Immune-Related Genes Model to Predict Treatment, Extracellular Matrix, and Prognosis of Head and Neck Squamous Cell Carcinoma.
Yang Y, Feng Y, Liu Q, Yin J, Cheng C, Fan C
Mediators Inflamm. 2023; 2023:6680731.
PMID: 37469759
PMC: 10353907.
DOI: 10.1155/2023/6680731.
Expression of YT Domain Family Protein in Oral Squamous Cell Carcinoma and Its Correlation with the Prognosis.
Shi R, Li S, Gao L, Zhi K, Ren W
Int J Gen Med. 2023; 16:2263-2270.
PMID: 37304901
PMC: 10256569.
DOI: 10.2147/IJGM.S407030.
Regulation of autophagy gene expression and its implications in cancer.
Metur S, Lei Y, Zhang Z, Klionsky D
J Cell Sci. 2023; 136(10).
PMID: 37199330
PMC: 10214848.
DOI: 10.1242/jcs.260631.